We examined the effect of the ChAdOx1 nCoV-19 vaccine on the frequencies of the total monocyte (CD14+) population and nonclassical/intermediate monocytes that coexpress CD16 (CD14+CD16+), which exert effector function in humans during infection and inflammation (19, 20). This evidence concerns the gene CD14 and infection.